ATOS
ATOSSA THERAPEUTICS, INC.
-0.05 (-2.07%)2.37USD6.5K成交股數23.7M市值–本益比(近四季)13453.3股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.9M | 4.8M | 6.2M | 5.4M | 5.5M | 4.2M | 3.4M | 3.6M | 3.7M | 5.7M | 4.5M | 3.7M |
| 銷售管理費用 | 3.8M | 5.1M | 5.3M | 3.9M | 3.5M | 3.3M | 3.0M | 3.6M | 3.2M | 3.4M | 3.0M | 4.1M |
| 營業利益 | −8.7M-4% | −9.9M+33% | −11.4M+79% | −9.3M+30% | −9.0M+30% | −7.4M-18% | −6.4M-15% | −7.1M-9% | −7.0M | −9.0M | −7.5M | −7.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −8.5M+1% | −9.6M+43% | −10.9M+51% | −8.7M+44% | −8.4M+43% | −6.7M-13% | −7.2M+16% | −6.0M-38% | −5.9M | −7.8M | −6.2M | −9.8M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.95-3% | -1.11+42% | -2.21+3583% | -0.07+40% | -0.98+1860% | -0.78+1200% | -0.06+20% | -0.05-38% | -0.05 | -0.06 | -0.05 | -0.08 |
| 稀釋股數 | 8.9M | 8.6M | 8.6M | 129M | 8.6M | 8.6M | 126M | 126M | 125M | 126M | 126M | 127M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 26.1M | 31.7M | 41.3M | 51.8M | 57.9M | 65.1M | 74.8M | 79.5M | 84.0M | 88.5M | 94.0M | 99.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 32.3M | 37.9M | 47.6M | 58.0M | 64.5M | 70.7M | 79.5M | 85.9M | 91.1M | 96.3M | 102M | 108M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 5.5M | 7.5M | 8.3M | 8.2M | 6.8M | 5.4M | 5.8M | 5.7M | 5.3M | 5.2M | 3.4M | 3.5M |
| 股東權益 | 26.8M | 30.5M | 39.4M | 49.8M | 57.7M | 65.3M | 73.7M | 80.2M | 85.8M | 91.0M | 98.3M | 105M |
| 負債比 | 16.9% | 19.7% | 17.3% | 14.2% | 10.6% | 7.7% | 7.3% | 6.6% | 5.8% | 5.4% | 3.4% | 3.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −9.6M+61% | – | – | – | −6.0M | – | – | −4.7M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 9K | – | – | 6K | – | – | – |
| 自由現金流 | – | −9.6M+61% | – | – | – | −6.0M | – | – | −4.7M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −34.8M | –% | -4.04 | −29.8M |
| FY2024 | – | – | −25.5M | –% | -3.04 | −21.0M |
| FY2023 | – | – | −30.1M | –% | -0.24 | −21.0M |
| FY2022 | – | – | −27.0M | –% | -0.21 | −20.8M |
| FY2021 | – | – | −20.6M | –% | -0.18 | −16.5M |
| FY2020 | – | – | −17.8M | –% | -1.97 | −11.6M |
| FY2019 | – | – | −17.2M | –% | -2.03 | −9.1M |
| FY2018 | – | – | −11.4M | –% | -5.50 | −9.1M |